Perfluorocarbon Perfused Vitrectomy and 3D Vitrectomy System in Advanced Diabetic Retinopathy
Sponsor
Asociación para Evitar la Ceguera en México (Other)
Overall Status
Unknown status
CT.gov ID
NCT00407108
Collaborator
(none)
1
3
Study Details
Study Description
Brief Summary
To investigate the feasibility and advantages of using perfluorocarbon liquid (PCL) perfusion to remove vitreous during suction-cutting vitrectomy using a dual, dynamic drive (3D)technology. In complicated surgeries in advanced diabetic retinopathy and retinal detachment
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Phase 3 |
Study Design
Study Type:
Interventional
Allocation:
Non-Randomized
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Study Start Date
:
Mar 1, 2006
Study Completion Date
:
Jun 1, 2006
Outcome Measures
Primary Outcome Measures
- Surgical time []
- Facility of surgical maneuvers []
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- Advanced diabetic retinopathy with retinal detachment
Exclusion Criteria:
- Retinal detachments of more than 6 months
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Asociación para Evitar la Ceguera en Mexico, Hospital "Luis Sanchez Bulnes" | Mexico City | Mexico DF | Mexico | 04030 |
Sponsors and Collaborators
- Asociación para Evitar la Ceguera en México
Investigators
- Principal Investigator: Hugo Quiroz-Mercado, MD, Asociación para Evitar la Ceguera en México
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
,
,
ClinicalTrials.gov Identifier:
NCT00407108
Other Study ID Numbers:
- APEC-005
First Posted:
Dec 4, 2006
Last Update Posted:
Dec 6, 2006
Last Verified:
Nov 1, 2006
Keywords provided by ,
,
Additional relevant MeSH terms: